Jessica Donington to Middle Aged
This is a "connection" page, showing publications Jessica Donington has written about Middle Aged.
Connection Strength
0.542
-
2020 Women in Thoracic Surgery Update on the Status of Women in Cardiothoracic Surgery. Ann Thorac Surg. 2022 03; 113(3):918-925.
Score: 0.053
-
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
Score: 0.051
-
STS 2019 Workforce Report: Ad Hoc Analysis of Women in Cardiothoracic Surgery. Ann Thorac Surg. 2021 02; 111(2):383-385.
Score: 0.051
-
Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 11; 160(5):1331-1345.e1.
Score: 0.049
-
Marjolin's Ulcer of the Pleural Surface Within a Long-Standing Eloesser Flap. Ann Thorac Surg. 2016 Nov; 102(5):e383-e385.
Score: 0.039
-
The WTS report on the current status of women in cardiothoracic surgery. Ann Thorac Surg. 2012 Aug; 94(2):452-8; discussion 458-9.
Score: 0.028
-
Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomark. 2012; 12(4):177-84.
Score: 0.028
-
Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20; 28(6):936-41.
Score: 0.024
-
Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006 Oct; 1(8):802-9.
Score: 0.019
-
Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus. Ann Thorac Surg. 2004 Apr; 77(4):1193-8; discussion 1198-9.
Score: 0.016
-
Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg. 2003 Oct; 24(4):631-6; discussion 636-7.
Score: 0.016
-
Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. JAMA Netw Open. 2023 08 01; 6(8):e2327351.
Score: 0.015
-
Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg. 2002 Jul; 74(1):154-8; discussion 158-9.
Score: 0.014
-
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
Score: 0.014
-
SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the Spike. mBio. 2021 01 19; 12(1).
Score: 0.013
-
Evaluation of the airway microbiome in nontuberculous mycobacteria disease. Eur Respir J. 2018 10; 52(4).
Score: 0.011
-
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. J Thorac Oncol. 2017 09; 12(9):1413-1420.
Score: 0.010
-
An Old Solution for a New Problem: Eloesser Flap Management of Infected Defibrillator Patches. Ann Thorac Surg. 2017 Jun; 103(6):e497-e498.
Score: 0.010
-
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. J Thorac Oncol. 2016 06; 11(6):900-9.
Score: 0.009
-
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. N Engl J Med. 2012 Oct 11; 367(15):1417-27.
Score: 0.007
-
A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2012 Sep; 115(3):694-702.
Score: 0.007
-
Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer. Clin Lung Cancer. 2011 Sep; 12(5):280-5.
Score: 0.007
-
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011 May; 6(5):920-6.
Score: 0.007
-
Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010 Oct; 5(10):1649-54.
Score: 0.006
-
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res. 2010 Mar 01; 70(5):1916-24.
Score: 0.006
-
Initial experience with endobronchial ultrasound in an academic thoracic surgery program. Clin Lung Cancer. 2010 Jan; 11(1):25-9.
Score: 0.006
-
Complications of ablative therapies in lung cancer. Clin Lung Cancer. 2008 Mar; 9(2):122-6.
Score: 0.005
-
Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007 Oct 01; 69(2):328-33.
Score: 0.005
-
A multidisciplinary approach to management in a patient with bilateral superior sulcus non-small-cell lung carcinoma. Clin Lung Cancer. 2006 Sep; 8(2):146-8.
Score: 0.005
-
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res. 2006 Mar 01; 12(5):1507-14.
Score: 0.005
-
Case 5--2005: anesthetic management of major hemorrhage during mediastinoscopy. [clin conf]. J Cardiothorac Vasc Anesth. 2005 Oct; 19(5):678-83.
Score: 0.004
-
Isolated lung perfusion with tumor necrosis factor for pulmonary metastases. Ann Thorac Surg. 1996 Jun; 61(6):1609-17.
Score: 0.002